2m 2m 2m 2m 2m 2m 2m
Ultragenyx Pharm (RARE)
NASDAQ
$29.02-$0.009 (-0.03%)
Price as of Jun 23, 2026 3:03 PM EDT- $2.9BMarket Cap
- -21.18%1-Year Change
- BiotechnologyIndustry
Ultragenyx Pharm (RARE)
$29.02-$0.009 (-0.03%)
RARE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.03 | ||
Change | +$1.59 (+5.79%) | ||
Open | $27.56 | ||
High | $29.35 | ||
Low | $27.49 | ||
Previous Close | $27.44 | ||
Volume | 2,067,508 | ||
30-Day Average Volume | 1,877,726 | ||
1-Week Change | 14.38% | ||
1-Month Change | 24.11% | ||
1-Year Change | -21.18% | ||
3-Year Change | -43.69% | ||
5-Year Change | -69.37% | ||
Fundamentals | |||
Shares Outstanding | 98.5M | ||
Total Assets | $1.3B | ||
Market Cap | $2.9B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | $89.0M | ||
Net Income | -$185.0M | ||
Free Cash Flow | -$198.0M | ||
EBIT | -$184.0M | ||
EBITDA | -$176.0M | ||
Net Working Capital | $332.0M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 30 | ||
P/B | -12 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue